J A Fagin

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.

S. Rubin, J. Fagin, H. Namba, 1990, Molecular endocrinology.

Clonal composition of benign and malignant human thyroid tumors.

J. Fagin, H. Namba, K. Matsuo, 1990, The Journal of clinical investigation.

Growth Hormone-Insulin-Like Growth Factor-I Axis in Adult Insulin-Dependent Diabetic Patients: Evidence for Central Hypersensitivity to Growth Hormone - Releasing Hormone and Peripheral Resistance to Growth Hormone

J. Fagin, R. Vaglio, L. Litwak, 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.

J. Fagin, J. Gross, G. Medeiros-Neto, 1996, The Journal of clinical endocrinology and metabolism.

H-ras protooncogene mutations in human thyroid neoplasms.

J. Fagin, H. Namba, K. Matsuo, 1990, The Journal of clinical endocrinology and metabolism.

Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.

M. Nikiforova, Y. Nikiforov, J. Fagin, 1996, Oncogene.